Public Health Initiatives by Takeda to strengthen health system for rare diseases in India

New Delhi, May 18: Takeda Biopharmaceuticals India Private Limited (formerly known as Baxalta Bioscience India Private Limited), a global values-based, R&D-driven biopharmaceutical leader conducted dissemination of its public health initiatives in strengthening the health system for rare diseases (RD) in India. These initiatives aim to improve access to healthcare for rare disease patients who otherwise face significant outcomes like childhood disabilities and life-long morbidity, early mortality, and progressively poor Quality of Life. The meeting was witnessed by Takeda's partners including APCO Worldwide, MAMTA Health Institute for Mother and Child, US-India Strategic Partnership Forum, and DakshamA Health and Education.

Related Keywords

New Delhi ,Delhi ,India ,Japan ,United States ,Joyeta Ghoshal ,Sunil Mehra ,Ruchi Sogarwal ,Takeda Public Health Initiative ,Dakshama Health ,Takeda Biopharmaceuticals India Private ,Head Of Corporate Affairs ,Exchange Commission ,National Policy For Rare Diseases ,Baxalta Bioscience India Private ,Takeda Pharmaceutical Company Limited ,Public Health ,Us India Strategic Partnership Forum ,Management Software For Pharmaceutical Business ,Health Institute For Mother ,Public Health Initiatives ,Takeda Biopharmaceuticals India Private Limited ,Baxalta Bioscience India Private Limited ,India Strategic Partnership Forum ,Corporate Affairs ,Takeda India ,National Policy ,Rare Diseases ,Senior Associate Director ,Executive Director ,Technical Support Unit ,Annual Report ,Lead Management Software ,Public Health Initiatives By Takeda To Strengthen System For Rare Diseases In India ,Public ,Health ,Initiatives ,Makeda ,Trengthen ,System ,Mare ,Diseases ,